Targeting Inflammation to Reduce Residual Cardiovascular Risk
Oluremi N Ajala, Brendan M. Everett
Topics & Concepts
MedicineMaceMyocardial infarctionInternal medicineCanakinumabResidual riskCoronary artery diseaseInflammationAcute coronary syndromeAdverse effectCardiologyDiseaseSubclinical infectionPercutaneous coronary interventionAnakinraInflammasome and immune disordersAdipokines, Inflammation, and Metabolic DiseasesBiomarkers in Disease Mechanisms